We are live on
!
Find out more
AI
Acuitas Investments Portfolio holdings
AUM
$1.43M
1-Year Est. Return
17.52%
This Fund
S&P 500
This Quarter
Est. Return
+4.56%
1 Year Est. Return
+17.52%
3 Year Est. Return
+145.17%
5 Year Est. Return
+267.61%
10 Year Est. Return
–
AUM
$170M
AUM Growth
-$1.63M
(-0.95%)
Cap. Flow
+$3.29M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
25.49%
Holding
122
New
16
Increased
33
Reduced
42
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INVX
Innovex International
INVX
|
+$2.12M |
| 2 |
Oportun Financial
OPRT
|
+$1.9M |
| 3 |
CHS
Chicos FAS, Inc.
CHS
|
+$1.87M |
| 4 |
Ramaco Resources Class B
METCB
|
+$1.81M |
| 5 |
MCHB
Mechanics Bancorp
MCHB
|
+$1.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sterling Infrastructure
STRL
|
+$3.1M |
| 2 |
Skywest
SKYW
|
+$1.86M |
| 3 |
Powell Industries
POWL
|
+$1.64M |
| 4 |
Natural Gas Services Group
NGS
|
+$1.49M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.73% |
| 2 | Technology | 12.99% |
| 3 | Healthcare | 12.08% |
| 4 | Energy | 11.93% |
| 5 | Consumer Staples | 11.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Fulcrum Therapeutics
FULC
$297M
| $599K | 0.35% |
134,811
-4
| -0% | -$17 |
|
77
Riskified
RSKD
$716M
| $569K | 0.33% |
+126,925
| New | +$585K |
|
78
Arteris
AIP
$1.38B
| $562K | 0.33% |
86,299
+21,946
| +34% | +$151K |
|
|
TRML
79
DELISTED
Tourmaline Bio
TRML
| $547K | 0.32% |
19,455
-29,659
| -60% | -$868K |
|
80
Astrotech Corp
ASTC
$17.8M
| $534K | 0.31% |
52,947
+9,638
| +22% | +$109K |
|
81
AMREP Corp
AXR
$119M
| $520K | 0.31% |
30,906
-1
| -0% | -$17 |
|
|
LENZ
82
LENZ Therapeutics
LENZ
$168M
| $485K | 0.29% |
27,966
-1
| -0% | -$17 |
|
83
Reading International Class A
RDI
$34.3M
| $479K | 0.28% |
226,084
-3
| -0% | -$7 |
|
84
Bolt Biotherapeutics
BOLT
$7.78M
| $479K | 0.28% |
23,019
| – | – |
|
85
Rafael Holdings
RFL
$107M
| $444K | 0.26% |
236,700
+8
| +0% | +$17 |
|
|
CMRX
86
DELISTED
Chimerix, Inc.
CMRX
| $439K | 0.26% |
457,791
-26
| -0% | -$28 |
|
|
ADVM
87
DELISTED
Adverum Biotechnologies
ADVM
| $437K | 0.26% |
29,117
-32,216
| -53% | -$578K |
|
88
Nektar Therapeutics
NKTR
$2.58B
| $430K | 0.25% |
48,097
-3
| -0% | -$29 |
|
|
KRON
89
DELISTED
Kronos Bio
KRON
| $427K | 0.25% |
328,821
-12
| -0% | -$19 |
|
90
Nuvation Bio
NUVB
$2.32B
| $424K | 0.25% |
316,499
-18
| -0% | -$30 |
|
|
LUMO
91
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $413K | 0.24% |
125,242
-28,625
| -19% | -$89.2K |
|
92
TAT Technologies
TATT
$515M
| $399K | 0.23% |
46,422
-17,514
| -27% | -$138K |
|
93
CKX Lands
CKX
$21.7M
| $385K | 0.23% |
29,318
-3,961
| -12% | -$45.1K |
|
|
SHPW
94
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
| $383K | 0.23% |
119,507
-4
| -0% | -$15 |
|
|
ADAP
95
DELISTED
Adaptimmune Therapeutics
ADAP
| $374K | 0.22% |
+479,764
| New | +$403K |
|
96
Atea Pharmaceuticals
AVIR
$420M
| $370K | 0.22% |
123,427
-3
| -0% | -$10 |
|
97
NextCure
NXTC
$26.7M
| $370K | 0.22% |
23,901
-2
| -0% | -$38 |
|
98
Invivyd
IVVD
$218M
| $355K | 0.21% |
+208,579
| New | +$331K |
|
|
RAIN
99
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $353K | 0.21% |
+409,256
| New | +$448K |
|
100
Coda Octopus Group
CODA
$120M
| $328K | 0.19% |
+52,925
| New | +$409K |
|
Similar funds
SH
HGCK
DF
DILIH
SCM
HB
SI
PA
Acuitas Investments's Q3 2023 Portfolio in Review
As of Q3 2023, Acuitas Investments held 122 positions worth $170M, down 0.95% from $172M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Acuitas Investments's Q3 2023 filing shows 16 new, 33 increased, 42 reduced and 7 closed positions. Its largest new stake was Innovex International: 77,964 shares worth $2.2M. The largest sale was Sterling Infrastructure, an estimated $3.1M.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Acuitas Investments's largest Q3 2023 buy was Innovex International: 77,964 shares worth $2.2M.
- Acuitas Investments added most to Chicos FAS, Inc. in Q3 2023, an estimated $1.87M increase.
- Acuitas Investments's biggest Q3 2023 reduction was Skywest, cutting an estimated $1.86M.
- Acuitas Investments fully exited Sterling Infrastructure in Q3 2023, selling an estimated $3.1M.
- Acuitas Investments's ten largest holdings make up 25% of its $170M portfolio in Q3 2023.
- Acuitas Investments opened 16 new positions and closed 7 in Q3 2023.
- Acuitas Investments's portfolio value fell 0.95% quarter-over-quarter to $170M.
Based on Acuitas Investments's 13F filing for Q3 2023, filed 27 Oct 2023.